Commercialisation and the Moral Obligation to Create 'Designer' Babies
By John Galloway,
BioNews
| 12. 08. 2014
Untitled Document
Although the word was not actually used (or at least I did not hear it), this was a polemic making the case for 'eugenics'. That is, the improvement, even 'perfection' perhaps, of humanity by actively intervening in its inherited biology.
In its pursuit, Professor Julian Savulescu, presenting the first session of the Progress Educational Trust's 2014 annual conference, The Commercialisation of Life, made a good case for parents being given more of a choice in the attributes of their children. After all, what's not to like in the idea of preventing inherited genetic diseases? Preventing diseases is what public health is all about, isn't it?
Read more...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...